173 related articles for article (PubMed ID: 23432696)
21. Relaxin-3/insulin-like peptide 7, a neuropeptide involved in the stress response and food intake.
Tanaka M
FEBS J; 2010 Dec; 277(24):4990-7. PubMed ID: 21126312
[TBL] [Abstract][Full Text] [Related]
22. Distribution of G-protein-coupled receptor (GPCR)135 binding sites and receptor mRNA in the rat brain suggests a role for relaxin-3 in neuroendocrine and sensory processing.
Sutton SW; Bonaventure P; Kuei C; Roland B; Chen J; Nepomuceno D; Lovenberg TW; Liu C
Neuroendocrinology; 2004; 80(5):298-307. PubMed ID: 15677880
[TBL] [Abstract][Full Text] [Related]
23. Probing the functional domains of relaxin-3 and the creation of a selective antagonist for RXFP3/GPCR135 over relaxin receptor RXFP1/LGR7.
Liu C; Kuei C; Sutton S; Shelton J; Zhu J; Nepomuceno D; Hossain MA; Wade JD; Bathgate RA; Bonaventure P; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():31-7. PubMed ID: 19416155
[TBL] [Abstract][Full Text] [Related]
24. Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications.
Ganella DE; Ryan PJ; Bathgate RA; Gundlach AL
Behav Pharmacol; 2012 Sep; 23(5-6):516-25. PubMed ID: 22854307
[TBL] [Abstract][Full Text] [Related]
25. Localization of relaxin-3 in brain of Macaca fascicularis: identification of a nucleus incertus in primate.
Ma S; Sang Q; Lanciego JL; Gundlach AL
J Comp Neurol; 2009 Dec; 517(6):856-72. PubMed ID: 19844992
[TBL] [Abstract][Full Text] [Related]
26. Relaxin-3 systems in the brain--the first 10 years.
Smith CM; Ryan PJ; Hosken IT; Ma S; Gundlach AL
J Chem Neuroanat; 2011 Dec; 42(4):262-75. PubMed ID: 21693186
[TBL] [Abstract][Full Text] [Related]
27. Enkephalin and neuropeptide-Y interaction in the intergeniculate leaflet network, a part of the mammalian biological clock.
Palus K; Chrobok L; Kepczynski M; Lewandowski MH
Neuroscience; 2017 Feb; 343():10-20. PubMed ID: 27916729
[TBL] [Abstract][Full Text] [Related]
28. Disinhibition of the intergeniculate leaflet network in the WAG/Rij rat model of absence epilepsy.
Chrobok L; Palus K; Jeczmien-Lazur JS; Chrzanowska A; Kepczynski M; Lewandowski MH
Exp Neurol; 2017 Mar; 289():103-116. PubMed ID: 28041911
[TBL] [Abstract][Full Text] [Related]
29. Signalling profiles of H3 relaxin, H2 relaxin and R3(BΔ23-27)R/I5 acting at the relaxin family peptide receptor 3 (RXFP3).
Kocan M; Sarwar M; Hossain MA; Wade JD; Summers RJ
Br J Pharmacol; 2014 Jun; 171(11):2827-41. PubMed ID: 24641548
[TBL] [Abstract][Full Text] [Related]
30. Estrous Cycle Modulation of Feeding and Relaxin-3/Rxfp3 mRNA Expression: Implications for Estradiol Action.
de Ávila C; Chometton S; Calvez J; Guèvremont G; Kania A; Torz L; Lenglos C; Blasiak A; Rosenkilde MM; Holst B; Conrad CD; Fryer JD; Timofeeva E; Gundlach AL; Cifani C
Neuroendocrinology; 2021; 111(12):1201-1218. PubMed ID: 33333517
[TBL] [Abstract][Full Text] [Related]
31. RLN3/RXFP3 Signaling in the PVN Inhibits Magnocellular Neurons via M-like Current Activation and Contributes to Binge Eating Behavior.
Kania A; Szlaga A; Sambak P; Gugula A; Blasiak E; Micioni Di Bonaventura MV; Hossain MA; Cifani C; Hess G; Gundlach AL; Blasiak A
J Neurosci; 2020 Jul; 40(28):5362-5375. PubMed ID: 32532885
[TBL] [Abstract][Full Text] [Related]
32. Metabolic and neuroendocrine responses to RXFP3 modulation in the central nervous system.
Sutton SW; Shelton J; Smith C; Williams J; Yun S; Motley T; Kuei C; Bonaventure P; Gundlach A; Liu C; Lovenberg T
Ann N Y Acad Sci; 2009 Apr; 1160():242-9. PubMed ID: 19416196
[TBL] [Abstract][Full Text] [Related]
33. Regulation of expression of relaxin-3 and its receptor RXFP3 in the brain of diet-induced obese rats.
Lenglos C; Mitra A; Guèvremont G; Timofeeva E
Neuropeptides; 2014 Jun; 48(3):119-32. PubMed ID: 24629399
[TBL] [Abstract][Full Text] [Related]
34. The structural and functional role of the B-chain C-terminal arginine in the relaxin-3 peptide antagonist, R3(BDelta23-27)R/I5.
Hossain MA; Bathgate RA; Rosengren KJ; Shabanpoor F; Zhang S; Lin F; Tregear GW; Wade JD
Chem Biol Drug Des; 2009 Jan; 73(1):46-52. PubMed ID: 19152634
[TBL] [Abstract][Full Text] [Related]
35. Development of a selective agonist for relaxin family peptide receptor 3.
Wei D; Hu MJ; Shao XX; Wang JH; Nie WH; Liu YL; Xu ZG; Guo ZY
Sci Rep; 2017 Jun; 7(1):3230. PubMed ID: 28607363
[TBL] [Abstract][Full Text] [Related]
36. Chronic activation of the relaxin-3 receptor on GABA neurons in rat ventral hippocampus promotes anxiety and social avoidance.
Rytova V; Ganella DE; Hawkes D; Bathgate RAD; Ma S; Gundlach AL
Hippocampus; 2019 Oct; 29(10):905-920. PubMed ID: 30891856
[TBL] [Abstract][Full Text] [Related]
37. Partial agonist activity of R3(BΔ23-27)R/I5 at RXFP3--investigation of in vivo and in vitro pharmacology.
Kristensson L; Mayer G; Ploj K; Wetterlund M; Arlbrandt S; Björquist A; Wissing BM; Castaldo M; Larsson N
Eur J Pharmacol; 2015 Jan; 747():123-31. PubMed ID: 25496752
[TBL] [Abstract][Full Text] [Related]
38. Involvement of Serotonergic and Relaxin-3 Neuropeptide Systems in the Expression of Anxiety-like Behavior.
Lawther AJ; Flavell A; Ma S; Kent S; Lowry CA; Gundlach AL; Hale MW
Neuroscience; 2018 Oct; 390():88-103. PubMed ID: 30125684
[TBL] [Abstract][Full Text] [Related]
39. Modulation of hippocampal theta oscillations and spatial memory by relaxin-3 neurons of the nucleus incertus.
Ma S; Olucha-Bordonau FE; Hossain MA; Lin F; Kuei C; Liu C; Wade JD; Sutton SW; Nuñez A; Gundlach AL
Learn Mem; 2009 Nov; 16(11):730-42. PubMed ID: 19880588
[TBL] [Abstract][Full Text] [Related]
40. Swim stress excitation of nucleus incertus and rapid induction of relaxin-3 expression via CRF1 activation.
Banerjee A; Shen PJ; Ma S; Bathgate RA; Gundlach AL
Neuropharmacology; 2010 Jan; 58(1):145-55. PubMed ID: 19560474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]